Table 1.
Characteristics | Total | High group | Low group | P value | |
---|---|---|---|---|---|
64 | N = 32 | N = 32 | |||
Age (years) | <60 | 23 | 10 | 13 | 0.434 |
≥ 60 | 41 | 22 | 19 | ||
Gender | Male | 38 | 20 | 18 | 0.611 |
Female | 26 | 12 | 14 | ||
HBsAg status | Positive | 48 | 25 | 23 | 0.564 |
Negative | 16 | 7 | 9 | ||
AFP (ng/ml) | <200 | 21 | 8 | 13 | 0.183 |
≥ 200 | 43 | 24 | 19 | ||
PIVKA-II(mAU/ml) | <40 | 25 | 11 | 14 | 0.442 |
≥ 40 | 39 | 21 | 18 | ||
Tumor multiplicity | Single | 35 | 16 | 19 | 0.451 |
Multiple | 29 | 16 | 13 | ||
Tumor diameter (cm) | ≤ 5 | 26 | 9 | 17 | 0.042* |
>5 | 38 | 23 | 15 | ||
TNM stage | I + II | 28 | 10 | 18 | 0.044* |
III + IV | 36 | 22 | 14 | ||
Microvascular invasion | Negative | 29 | 12 | 17 | 0.209 |
Positive | 35 | 20 | 15 |
AFP, alpha fetoprotein; PIVKA-II, Protein Induced by Vitamin K Absence or Antagonist II; HBsAg, hepatitis B surface antigen
*P < 0.05